Mini Review
Toxicity of maintenance drugs in Inflammatory Bowel Disease
Abdo Saad MD1*
1Department of Internal Medicine, Section of Gastroenterology, Lebanese American University, Lebanon
Abdo Saad MD, Department of Internal Medicine, Section of Gastroenterology, Lebanese American University, Lebanon.
Received Date: August 04, 2021; Published Date: September 07, 2021
Abstract
Inflammatory bowel disease is a chronic condition requiring long-term treatment with immunosuppressive medications. There is concern regarding the risks of drug-related toxicity particularly the risk of infections and the risk of malignancy. Pregnancy requires a particular consideration due to the implications from the exposure to the fetus and elderly patients may be at a higher risk of toxicity that merits special precautions.
Keywords: 5-Aminosalicylates; Immunomodulators; Biologics; Toxicity; Inflammatory Bowel Disease; Crohn’s Disease; Ulcerative Colitis
-
Abdo Saad. Toxicity of maintenance drugs in Inflammatory Bowel Disease. Open J Pathol Toxicol Res. 1(1): 2021. OJPTR.MS.ID.000502.
-
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.